We further observed that MD serum significantly decreased the lapidated form of MAP1L3B/LC3B (microtubule-associated protein one light chain three beta; LC3B-II), which was increased by DOX treatment (Figure 8C). Here, MAP1LC3B is linked to Menkes disease.